The U.S. dental bone graft substitute (DBGS) and biomaterials market was valued at $650 million in 2024 and is projected to grow at a CAGR of 6.8%, reaching over $1.0 billion by 2031.
Market growth is driven by:
Advancements in regenerative dental treatments.
Increasing demand for dental implants and periodontal procedures.
Growing adoption of dental biomaterials for tissue regeneration.
The 2025 report suite covers:
Dental Bone Graft Substitutes
Dental Growth Factors
Dental Barrier Membranes
Local Antimicrobial Periodontal Treatments
Dental Soft Tissue Regeneration
Collectively, these segments make up the dental biomaterials market.
Market Report Data Types Included
Unit Sales & Average Selling Prices (ASP)
Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2031
Historical Data (2021-2023)
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
Company Profiles & Product Portfolios
Leading Competitors
U.S. Dental Bone Graft Substitute Market Trends
Limited Insurance Coverage Restricts Market Growth:
Most dental insurance plans do not cover implant and bone grafting procedures, leading to high out-of-pocket costs for patients.
Economic disparities limit access to advanced periodontal treatments.
Expanding insurance coverage could significantly increase procedural volume and drive market demand.
Market Growth Linked to Dental Implant Demand:
Bone graft substitutes are widely used in dental implant procedures.
As dental implant adoption rises, so does demand for regenerative materials.
U.S. Dental Bone Graft Substitute Market Share Insights (2024)
1 Geistlich – Market Leader
Dominant player in the DBGS and biomaterials market.
Strong presence in the dental bone graft substitute, dental barrier membrane, and soft tissue regeneration segments.
Key products include Bio-Oss®, Bio-Gide®, and Mucograft®.
Acquisition of Lynch Biologics in 2022 expanded its portfolio with GEM 21S®, reinforcing its leadership in dental growth factors.
2 ZimVie – Second-Largest Competitor
Broad portfolio across multiple dental biomaterial segments.
Key products include Puros® Allograft, Regeneross® line, and IngeniOs® synthetics.
Offers high-quality alternatives competing with top DBGS brands.
3 OraPharma – Third-Largest Competitor
Leader in the local antimicrobial periodontal treatment segment.
Flagship product ARESTIN® (minocycline HCl) Microspheres, 1 mg enhances periodontal treatment effectiveness.
Strong presence in periodontal disease management.
Market Segmentation Summary
Dental Bone Graft Substitute Market – Further segmented into:
Mineralized Allograft
Demineralized Bone Matrix (DMB) Allograft
Xenograft
Synthetics
Dental Growth Factor Market – Further segmented into:
Emdogain
GEM 21S®
Infuse
Osteocel®
Dental Barrier Membrane Market – Further segmented into:
Resorbable Membranes
Non-Resorbable Membranes
Local Antimicrobial Periodontal Treatment Market
Dental Soft Tissue Regeneration Market – Further segmented into:
Regeneration
Wound Care
Research Scope Summary
Regions Covered
United States
Base Year: 2024
Forecast Period: 2025-2031
Historical Data: 2021-2023
Quantitative Coverage
Market Size & Growth Rates
Procedure Numbers
Unit Sales & ASP
Market Shares & Forecasts through 2031
Qualitative Coverage
Market Growth Trends & Limiters
Competitive Analysis & SWOT for Top Competitors
Mergers & Acquisitions
Company Profiles & Product Portfolios
FDA Recalls & Regulatory Developments
Disruptive Technologies & Emerging Innovations
Disease Overviews
Data Sources
Primary Interviews with Industry Leaders
Government Physician Data
Regulatory Data
Hospital Private Data
Import & Export Data
iData Research Internal Database
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook